Corticosteroid treatment has no effect on hospital mortality in COVID-19 patients
Abstract Since the start of the novel coronavirus 2019 (COVID-19) pandemic, corticosteroid use has been the subject of debate. The available evidence is uncertain, and knowledge on the subject is evolving. The aim of our cohort study was to evaluate the association between corticosteroid therapy and...
Guardado en:
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/babde8d5383440d1a3578de4d3f1d5e9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:babde8d5383440d1a3578de4d3f1d5e9 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:babde8d5383440d1a3578de4d3f1d5e92021-12-02T14:12:42ZCorticosteroid treatment has no effect on hospital mortality in COVID-19 patients10.1038/s41598-020-80654-x2045-2322https://doaj.org/article/babde8d5383440d1a3578de4d3f1d5e92021-01-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-80654-xhttps://doaj.org/toc/2045-2322Abstract Since the start of the novel coronavirus 2019 (COVID-19) pandemic, corticosteroid use has been the subject of debate. The available evidence is uncertain, and knowledge on the subject is evolving. The aim of our cohort study was to evaluate the association between corticosteroid therapy and hospital mortality, in patients hospitalized with COVID-19 after balancing for possible confounders. One thousand four hundred forty four patients were admitted to our hospital with a positive RT-PCR test for SARS-CoV-2, 559 patients (39%) were exposed to corticosteroids during hospital stay, 844 (61%) were not exposed to corticosteroids. In the cohort of patients exposed to corticosteroids, 171 (30.6%) died. In the cohort of patients not exposed to corticosteroids, 183 (21.7%) died (unadjusted p < 0.001). Nonetheless, exposure to corticosteroids was not associated with in-hospital mortality after balancing with overlap weight propensity score (adjusted p = 0.25). Patients in the corticosteroids cohort had a reduced risk of ICU admission (adjusted p < 0.001). Treatment with corticosteroids did not affect hospital mortality in patients with COVID-19 after balancing for confounders. A possible advantage of corticosteroid therapy was to reduce Intensive Care Unit admission, which could be useful in reducing pressure on Intensive Care Units in times of limited resources, as during the COVID-19 pandemic.Filippo AlbaniFederica FusinaEnza GranatoCristina CapotostoClaudia CeracchiRiccardo GargarutiGiovanni SantangeloLuca SchiavoneMaria Salvatrice TarantoCinzia TosatiElena VavassoriGiuseppe NataliniNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-6 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Filippo Albani Federica Fusina Enza Granato Cristina Capotosto Claudia Ceracchi Riccardo Gargaruti Giovanni Santangelo Luca Schiavone Maria Salvatrice Taranto Cinzia Tosati Elena Vavassori Giuseppe Natalini Corticosteroid treatment has no effect on hospital mortality in COVID-19 patients |
description |
Abstract Since the start of the novel coronavirus 2019 (COVID-19) pandemic, corticosteroid use has been the subject of debate. The available evidence is uncertain, and knowledge on the subject is evolving. The aim of our cohort study was to evaluate the association between corticosteroid therapy and hospital mortality, in patients hospitalized with COVID-19 after balancing for possible confounders. One thousand four hundred forty four patients were admitted to our hospital with a positive RT-PCR test for SARS-CoV-2, 559 patients (39%) were exposed to corticosteroids during hospital stay, 844 (61%) were not exposed to corticosteroids. In the cohort of patients exposed to corticosteroids, 171 (30.6%) died. In the cohort of patients not exposed to corticosteroids, 183 (21.7%) died (unadjusted p < 0.001). Nonetheless, exposure to corticosteroids was not associated with in-hospital mortality after balancing with overlap weight propensity score (adjusted p = 0.25). Patients in the corticosteroids cohort had a reduced risk of ICU admission (adjusted p < 0.001). Treatment with corticosteroids did not affect hospital mortality in patients with COVID-19 after balancing for confounders. A possible advantage of corticosteroid therapy was to reduce Intensive Care Unit admission, which could be useful in reducing pressure on Intensive Care Units in times of limited resources, as during the COVID-19 pandemic. |
format |
article |
author |
Filippo Albani Federica Fusina Enza Granato Cristina Capotosto Claudia Ceracchi Riccardo Gargaruti Giovanni Santangelo Luca Schiavone Maria Salvatrice Taranto Cinzia Tosati Elena Vavassori Giuseppe Natalini |
author_facet |
Filippo Albani Federica Fusina Enza Granato Cristina Capotosto Claudia Ceracchi Riccardo Gargaruti Giovanni Santangelo Luca Schiavone Maria Salvatrice Taranto Cinzia Tosati Elena Vavassori Giuseppe Natalini |
author_sort |
Filippo Albani |
title |
Corticosteroid treatment has no effect on hospital mortality in COVID-19 patients |
title_short |
Corticosteroid treatment has no effect on hospital mortality in COVID-19 patients |
title_full |
Corticosteroid treatment has no effect on hospital mortality in COVID-19 patients |
title_fullStr |
Corticosteroid treatment has no effect on hospital mortality in COVID-19 patients |
title_full_unstemmed |
Corticosteroid treatment has no effect on hospital mortality in COVID-19 patients |
title_sort |
corticosteroid treatment has no effect on hospital mortality in covid-19 patients |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/babde8d5383440d1a3578de4d3f1d5e9 |
work_keys_str_mv |
AT filippoalbani corticosteroidtreatmenthasnoeffectonhospitalmortalityincovid19patients AT federicafusina corticosteroidtreatmenthasnoeffectonhospitalmortalityincovid19patients AT enzagranato corticosteroidtreatmenthasnoeffectonhospitalmortalityincovid19patients AT cristinacapotosto corticosteroidtreatmenthasnoeffectonhospitalmortalityincovid19patients AT claudiaceracchi corticosteroidtreatmenthasnoeffectonhospitalmortalityincovid19patients AT riccardogargaruti corticosteroidtreatmenthasnoeffectonhospitalmortalityincovid19patients AT giovannisantangelo corticosteroidtreatmenthasnoeffectonhospitalmortalityincovid19patients AT lucaschiavone corticosteroidtreatmenthasnoeffectonhospitalmortalityincovid19patients AT mariasalvatricetaranto corticosteroidtreatmenthasnoeffectonhospitalmortalityincovid19patients AT cinziatosati corticosteroidtreatmenthasnoeffectonhospitalmortalityincovid19patients AT elenavavassori corticosteroidtreatmenthasnoeffectonhospitalmortalityincovid19patients AT giuseppenatalini corticosteroidtreatmenthasnoeffectonhospitalmortalityincovid19patients |
_version_ |
1718391806731747328 |